Pond Technologies

Microdose Psychedelic Insights Announces Entheon Biomedical, Levitee Labs, and Women in Psychedelics to take centre stage at Psychedelic Capital: September 30, 2021

23 September 2021

Microdose Psychedelic Insights is proud to announce the upcoming Psychedelic Capital: September 2021 conference to be taking place on September 30, 2021, starting at 1:30pm EDT. The September edition will engage in discussions on Novel Psychedelic Molecules and Women in Psychedelics: Exploring the role of research and therapeutic experiences. The conference will play host to a number of corporate presentations, including Entheon Biomedical (OTCQB: ENTBF) (FSE: 1XU1) and Levitee Labs (OTC Pink: LVTTF).

Click here to get a free ticket: https://microdose.buzz/pressrelease.

The virtual event will seek to provide attendees with some of the top companies, latest IPOs, newest opportunities, and deepest industry insights within the sector.

Part of an investor conference series diving deep into psychedelic medicine investment, Psychedelic Capital conferences seek to introduce investors and attendees to a curated group of CEOs, capital advisors, and investment luminaries from around the world.

"Novel molecules have the potential to make psychedelic medicine more accessible and enjoyable for the average patient - not to mention, big returns for investors. But with this opportunity comes scientific uncertainty and financial risk. In [the Novel Psychedelic Molecules] panel, we'll speak to some of the leaders in novel molecule development and learn how they navigate the promise and perils of this exciting space." - Brom Rector, Founder, Empath Ventures/The Integration Conversation.

"The psychedelic industry exists at the crossroads between years of practical therapeutic experiences and emerging scientific research. On the Women in Psychedelics panel we'll explore this intersection and the opportunities for women in this rapidly evolving industry. As an industry it's important we build equitable and diverse companies by including psychedelic pioneers and welcoming new talent." - Katie Pringle, Co-Founder & CEO of Marigold Marketing and PR.

Women in Psychedelics: Exploring the role of research and therapeutic experiences
panel features: Susan Chapelle, Kelsey Ramsden, and Katie Pringle as moderator.

''Microdose is honored to celebrate women in the psychedelics space and provide our platform to amplify diverse voices of all kinds.'' - Christina Cassen, Microdose Psychedelic Insights, Chief of Staff.

The conference will seek to enable attendees to build relationships, network with professionals from across the psychedelics industry, and gain access to exciting and ground-breaking pre-IPO investment opportunities within the wider sector.

Additional information about the Psychedelic Capital: September 2021 conference, as well as details for registration, can be found here: https://microdose.buzz/pressrelease.

Notes to Editors
To request media accreditation, or to arrange interviews with key personnel please contact:
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.

About Microdose Psychedelic Insights

Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.

About PsyCap

This online event programming is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.

Sign Up To Get Daily Green Stock News In Your Inbox

Please review our Disclaimer and Privacy Policy before subscribing.

STOCK QUOTE

FEATURED GREEN STOCK

LithiumBank Resources

LithiumBank Resources is creating an opportunity to participate in the future of clean-tech energy. The company's strategy is to acquire claims in known lithium high grade hot spots with existing wells and infrastructure...

CLICK TO LEARN MORE

FEATURED GREEN STOCK

GreenPower Motor

GreenPower Motor designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo van, and a cab and chassis...

CLICK TO LEARN MORE

COPYRIGHT ©2022 GREEN STOCK NEWS